Global Drug-Eluting Stents Sales Market Report 2018

Publisher Name :
Date: 13-Apr-2018
No. of pages: 114
Inquire Before Buying

This report studies the global Drug-Eluting Stents market status and forecast, categorizes the global Drug-Eluting Stents market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

In 2017, the global Drug-Eluting Stents market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx.x % between 2018 and 2025.

The major players covered in this report

- Abbott Vascular

- Advantec Vascular

- B.Braun Melsengen AG

- Biosensors

- Biotronik

- Blue Medical

- Boston Scientific

- DISA Vascular

- Essen

- Medtronic Vascular

- MicroPort Medical

- MIV Therapeutics

- Orbusneich

- Promed Medical

- Relisys Medical

- Reva Medical

- Sahajanand

- Sino Medical

- Sorin

- Terumo Medical

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

- United States

- Europe

- China

- Japan

- Southeast Asia

- India

The regional scope of the study is as follows:

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Rest of Asia-Pacific

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- - Rest of Europe

- Central & South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Saudi Arabia

- - Turkey

- - Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Cobalt-chromium alloy Stents

- Magnesium alloy Stents

- Tyrosine polycarbonate Stents

- Nitinol Stents

- Platinum chromium alloy Stents

- Stainless steel Stents

- Other Materials

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

- Coronary Heart Disease

- Clinical

The study objectives of this report are:

- To analyze and study the global Drug-Eluting Stents sales, value, status (2013-2017) and forecast (2018-2025);

- To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.

- Focuses on the key Drug-Eluting Stents players, to study the sales, value, market share and development plans in future.

- Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.

- To define, describe and forecast the market by type, application and region.

- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

- To identify significant trends and factors driving or inhibiting the market growth.

- To analyze the opportunities in the market for stakeholders by identifying the high growth segments.

- To strategically analyze each submarket with respect to individual growth trend and their contribution to the market

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

- To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Drug-Eluting Stents are as follows:

- History Year: 2013-2017

- Base Year: 2017

- Estimated Year: 2018

- Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Drug-Eluting Stents Manufacturers

Drug-Eluting Stents Distributors/Traders/Wholesalers

Drug-Eluting Stents Subcomponent Manufacturers

Industry Association

Downstream Vendors

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Regional and country-level analysis of the Drug-Eluting Stents market, by end-use.

Detailed analysis and profiles of additional market players.

Global Drug-Eluting Stents Sales Market Report 2018

Table of Contents
Global Drug-Eluting Stents Sales Market Report 2018
1 Drug-Eluting Stents Market Overview
1.1 Product Overview and Scope of Drug-Eluting Stents
1.2 Classification of Drug-Eluting Stents by Product Category
1.2.1 Global Drug-Eluting Stents Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Drug-Eluting Stents Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Cobalt-chromium alloy Stents
1.2.4 Magnesium alloy Stents
1.2.5 Tyrosine polycarbonate Stents
1.2.6 Nitinol Stents
1.2.7 Platinum chromium alloy Stents
1.2.8 Stainless steel Stents
1.2.9 Other Materials
1.3 Global Drug-Eluting Stents Market by Application/End Users
1.3.1 Global Drug-Eluting Stents Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.2 Coronary Heart Disease
1.3.3 Clinical
1.4 Global Drug-Eluting Stents Market by Region
1.4.1 Global Drug-Eluting Stents Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Drug-Eluting Stents Status and Prospect (2013-2025)
1.4.3 Europe Drug-Eluting Stents Status and Prospect (2013-2025)
1.4.4 China Drug-Eluting Stents Status and Prospect (2013-2025)
1.4.5 Japan Drug-Eluting Stents Status and Prospect (2013-2025)
1.4.6 Southeast Asia Drug-Eluting Stents Status and Prospect (2013-2025)
1.4.7 India Drug-Eluting Stents Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Drug-Eluting Stents (2013-2025)
1.5.1 Global Drug-Eluting Stents Sales and Growth Rate (2013-2025)
1.5.2 Global Drug-Eluting Stents Revenue and Growth Rate (2013-2025)
2 Global Drug-Eluting Stents Competition by Players/Suppliers, Type and Application
2.1 Global Drug-Eluting Stents Market Competition by Players/Suppliers
2.1.1 Global Drug-Eluting Stents Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Drug-Eluting Stents Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Drug-Eluting Stents (Volume and Value) by Type
2.2.1 Global Drug-Eluting Stents Sales and Market Share by Type (2013-2018)
2.2.2 Global Drug-Eluting Stents Revenue and Market Share by Type (2013-2018)
2.3 Global Drug-Eluting Stents (Volume and Value) by Region
2.3.1 Global Drug-Eluting Stents Sales and Market Share by Region (2013-2018)
2.3.2 Global Drug-Eluting Stents Revenue and Market Share by Region (2013-2018)
2.4 Global Drug-Eluting Stents (Volume) by Application
3 United States Drug-Eluting Stents (Volume, Value and Sales Price)
3.1 United States Drug-Eluting Stents Sales and Value (2013-2018)
3.1.1 United States Drug-Eluting Stents Sales and Growth Rate (2013-2018)
3.1.2 United States Drug-Eluting Stents Revenue and Growth Rate (2013-2018)
3.1.3 United States Drug-Eluting Stents Sales Price Trend (2013-2018)
3.2 United States Drug-Eluting Stents Sales Volume and Market Share by Players (2013-2018)
3.3 United States Drug-Eluting Stents Sales Volume and Market Share by Type (2013-2018)
3.4 United States Drug-Eluting Stents Sales Volume and Market Share by Application (2013-2018)
4 Europe Drug-Eluting Stents (Volume, Value and Sales Price)
4.1 Europe Drug-Eluting Stents Sales and Value (2013-2018)
4.1.1 Europe Drug-Eluting Stents Sales and Growth Rate (2013-2018)
4.1.2 Europe Drug-Eluting Stents Revenue and Growth Rate (2013-2018)
4.1.3 Europe Drug-Eluting Stents Sales Price Trend (2013-2018)
4.2 Europe Drug-Eluting Stents Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Drug-Eluting Stents Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Drug-Eluting Stents Sales Volume and Market Share by Application (2013-2018)
5 China Drug-Eluting Stents (Volume, Value and Sales Price)
5.1 China Drug-Eluting Stents Sales and Value (2013-2018)
5.1.1 China Drug-Eluting Stents Sales and Growth Rate (2013-2018)
5.1.2 China Drug-Eluting Stents Revenue and Growth Rate (2013-2018)
5.1.3 China Drug-Eluting Stents Sales Price Trend (2013-2018)
5.2 China Drug-Eluting Stents Sales Volume and Market Share by Players (2013-2018)
5.3 China Drug-Eluting Stents Sales Volume and Market Share by Type (2013-2018)
5.4 China Drug-Eluting Stents Sales Volume and Market Share by Application (2013-2018)
6 Japan Drug-Eluting Stents (Volume, Value and Sales Price)
6.1 Japan Drug-Eluting Stents Sales and Value (2013-2018)
6.1.1 Japan Drug-Eluting Stents Sales and Growth Rate (2013-2018)
6.1.2 Japan Drug-Eluting Stents Revenue and Growth Rate (2013-2018)
6.1.3 Japan Drug-Eluting Stents Sales Price Trend (2013-2018)
6.2 Japan Drug-Eluting Stents Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Drug-Eluting Stents Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Drug-Eluting Stents Sales Volume and Market Share by Application (2013-2018)
7 Southeast Asia Drug-Eluting Stents (Volume, Value and Sales Price)
7.1 Southeast Asia Drug-Eluting Stents Sales and Value (2013-2018)
7.1.1 Southeast Asia Drug-Eluting Stents Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Drug-Eluting Stents Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Drug-Eluting Stents Sales Price Trend (2013-2018)
7.2 Southeast Asia Drug-Eluting Stents Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Drug-Eluting Stents Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Drug-Eluting Stents Sales Volume and Market Share by Application (2013-2018)
8 India Drug-Eluting Stents (Volume, Value and Sales Price)
8.1 India Drug-Eluting Stents Sales and Value (2013-2018)
8.1.1 India Drug-Eluting Stents Sales and Growth Rate (2013-2018)
8.1.2 India Drug-Eluting Stents Revenue and Growth Rate (2013-2018)
8.1.3 India Drug-Eluting Stents Sales Price Trend (2013-2018)
8.2 India Drug-Eluting Stents Sales Volume and Market Share by Players (2013-2018)
8.3 India Drug-Eluting Stents Sales Volume and Market Share by Type (2013-2018)
8.4 India Drug-Eluting Stents Sales Volume and Market Share by Application (2013-2018)
9 Global Drug-Eluting Stents Players/Suppliers Profiles and Sales Data
9.1 Abbott Vascular
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Drug-Eluting Stents Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Abbott Vascular Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Advantec Vascular
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Drug-Eluting Stents Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Advantec Vascular Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 B.Braun Melsengen AG
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Drug-Eluting Stents Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 B.Braun Melsengen AG Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Biosensors
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Drug-Eluting Stents Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Biosensors Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Biotronik
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Drug-Eluting Stents Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Biotronik Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Blue Medical
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Drug-Eluting Stents Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Blue Medical Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Boston Scientific
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Drug-Eluting Stents Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Boston Scientific Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 DISA Vascular
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Drug-Eluting Stents Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 DISA Vascular Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview
9.9 Essen
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Drug-Eluting Stents Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Essen Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2013-2018)
9.9.4 Main Business/Business Overview
9.10 Medtronic Vascular
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Drug-Eluting Stents Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Medtronic Vascular Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2013-2018)
9.10.4 Main Business/Business Overview
9.11 MicroPort Medical
9.12 MIV Therapeutics
9.13 Orbusneich
9.14 Promed Medical
9.15 Relisys Medical
9.16 Reva Medical
9.17 Sahajanand
9.18 Sino Medical
9.19 Sorin
9.20 Terumo Medical
10 Drug-Eluting Stents Maufacturing Cost Analysis
10.1 Drug-Eluting Stents Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Drug-Eluting Stents
10.3 Manufacturing Process Analysis of Drug-Eluting Stents
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Drug-Eluting Stents Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Drug-Eluting Stents Major Manufacturers in 2017
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Drug-Eluting Stents Market Forecast (2018-2025)
14.1 Global Drug-Eluting Stents Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Drug-Eluting Stents Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Drug-Eluting Stents Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Drug-Eluting Stents Price and Trend Forecast (2018-2025)
14.2 Global Drug-Eluting Stents Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Drug-Eluting Stents Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Drug-Eluting Stents Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Drug-Eluting Stents Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Drug-Eluting Stents Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Drug-Eluting Stents Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Drug-Eluting Stents Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Drug-Eluting Stents Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Drug-Eluting Stents Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Drug-Eluting Stents Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Drug-Eluting Stents Sales Forecast by Type (2018-2025)
14.3.2 Global Drug-Eluting Stents Revenue Forecast by Type (2018-2025)
14.3.3 Global Drug-Eluting Stents Price Forecast by Type (2018-2025)
14.4 Global Drug-Eluting Stents Sales Volume Forecast by Application (2018-2025)
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Drug-Eluting Stents
Figure Global Drug-Eluting Stents Sales Volume Comparison (K Units) by Type (2013-2025)
Figure Global Drug-Eluting Stents Sales Volume Market Share by Type (Product Category) in 2017
Figure Cobalt-chromium alloy Stents Product Picture
Figure Magnesium alloy Stents Product Picture
Figure Tyrosine polycarbonate Stents Product Picture
Figure Nitinol Stents Product Picture
Figure Platinum chromium alloy Stents Product Picture
Figure Stainless steel Stents Product Picture
Figure Other Materials Product Picture
Figure Global Drug-Eluting Stents Sales Comparison (K Units) by Application (2013-2025)
Figure Global Sales Market Share of Drug-Eluting Stents by Application in 2017
Figure Coronary Heart Disease Examples
Table Key Downstream Customer in Coronary Heart Disease
Figure Clinical Examples
Table Key Downstream Customer in Clinical
Figure Global Drug-Eluting Stents Market Size (Million USD) by Regions (2013-2025)
Figure United States Drug-Eluting Stents Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Drug-Eluting Stents Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Drug-Eluting Stents Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Drug-Eluting Stents Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Drug-Eluting Stents Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Drug-Eluting Stents Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Drug-Eluting Stents Sales Volume (K Units) and Growth Rate (2013-2025)
Figure Global Drug-Eluting Stents Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Drug-Eluting Stents Sales Volume (K Units) (2013-2018)
Table Global Drug-Eluting Stents Sales (K Units) of Key Players/Suppliers (2013-2018)
Table Global Drug-Eluting Stents Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Drug-Eluting Stents Sales Share by Players/Suppliers
Figure 2017 Drug-Eluting Stents Sales Share by Players/Suppliers
Figure Global Drug-Eluting Stents Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Drug-Eluting Stents Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Drug-Eluting Stents Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Drug-Eluting Stents Revenue Share by Players
Table 2017 Global Drug-Eluting Stents Revenue Share by Players
Table Global Drug-Eluting Stents Sales (K Units) and Market Share by Type (2013-2018)
Table Global Drug-Eluting Stents Sales Share (K Units) by Type (2013-2018)
Figure Sales Market Share of Drug-Eluting Stents by Type (2013-2018)
Figure Global Drug-Eluting Stents Sales Growth Rate by Type (2013-2018)
Table Global Drug-Eluting Stents Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Drug-Eluting Stents Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Drug-Eluting Stents by Type (2013-2018)
Figure Global Drug-Eluting Stents Revenue Growth Rate by Type (2013-2018)
Table Global Drug-Eluting Stents Sales Volume (K Units) and Market Share by Region (2013-2018)
Table Global Drug-Eluting Stents Sales Share by Region (2013-2018)
Figure Sales Market Share of Drug-Eluting Stents by Region (2013-2018)
Figure Global Drug-Eluting Stents Sales Growth Rate by Region in 2017
Table Global Drug-Eluting Stents Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Drug-Eluting Stents Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Drug-Eluting Stents by Region (2013-2018)
Figure Global Drug-Eluting Stents Revenue Growth Rate by Region in 2017
Table Global Drug-Eluting Stents Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Drug-Eluting Stents Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Drug-Eluting Stents by Region (2013-2018)
Figure Global Drug-Eluting Stents Revenue Market Share by Region in 2017
Table Global Drug-Eluting Stents Sales Volume (K Units) and Market Share by Application (2013-2018)
Table Global Drug-Eluting Stents Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Drug-Eluting Stents by Application (2013-2018)
Figure Global Drug-Eluting Stents Sales Market Share by Application (2013-2018)
Figure United States Drug-Eluting Stents Sales (K Units) and Growth Rate (2013-2018)
Figure United States Drug-Eluting Stents Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Drug-Eluting Stents Sales Price (USD/Unit) Trend (2013-2018)
Table United States Drug-Eluting Stents Sales Volume (K Units) by Players (2013-2018)
Table United States Drug-Eluting Stents Sales Volume Market Share by Players (2013-2018)
Figure United States Drug-Eluting Stents Sales Volume Market Share by Players in 2017
Table United States Drug-Eluting Stents Sales Volume (K Units) by Type (2013-2018)
Table United States Drug-Eluting Stents Sales Volume Market Share by Type (2013-2018)
Figure United States Drug-Eluting Stents Sales Volume Market Share by Type in 2017
Table United States Drug-Eluting Stents Sales Volume (K Units) by Application (2013-2018)
Table United States Drug-Eluting Stents Sales Volume Market Share by Application (2013-2018)
Figure United States Drug-Eluting Stents Sales Volume Market Share by Application in 2017
Figure Europe Drug-Eluting Stents Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Drug-Eluting Stents Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Drug-Eluting Stents Sales Price (USD/Unit) Trend (2013-2018)
Table Europe Drug-Eluting Stents Sales Volume (K Units) by Players (2013-2018)
Table Europe Drug-Eluting Stents Sales Volume Market Share by Players (2013-2018)
Figure Europe Drug-Eluting Stents Sales Volume Market Share by Players in 2017
Table Europe Drug-Eluting Stents Sales Volume (K Units) by Type (2013-2018)
Table Europe Drug-Eluting Stents Sales Volume Market Share by Type (2013-2018)
Figure Europe Drug-Eluting Stents Sales Volume Market Share by Type in 2017
Table Europe Drug-Eluting Stents Sales Volume (K Units) by Application (2013-2018)
Table Europe Drug-Eluting Stents Sales Volume Market Share by Application (2013-2018)
Figure Europe Drug-Eluting Stents Sales Volume Market Share by Application in 2017
Figure China Drug-Eluting Stents Sales (K Units) and Growth Rate (2013-2018)
Figure China Drug-Eluting Stents Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Drug-Eluting Stents Sales Price (USD/Unit) Trend (2013-2018)
Table China Drug-Eluting Stents Sales Volume (K Units) by Players (2013-2018)
Table China Drug-Eluting Stents Sales Volume Market Share by Players (2013-2018)
Figure China Drug-Eluting Stents Sales Volume Market Share by Players in 2017
Table China Drug-Eluting Stents Sales Volume (K Units) by Type (2013-2018)
Table China Drug-Eluting Stents Sales Volume Market Share by Type (2013-2018)
Figure China Drug-Eluting Stents Sales Volume Market Share by Type in 2017
Table China Drug-Eluting Stents Sales Volume (K Units) by Application (2013-2018)
Table China Drug-Eluting Stents Sales Volume Market Share by Application (2013-2018)
Figure China Drug-Eluting Stents Sales Volume Market Share by Application in 2017
Figure Japan Drug-Eluting Stents Sales (K Units) and Growth Rate (2013-2018)
Figure Japan Drug-Eluting Stents Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Drug-Eluting Stents Sales Price (USD/Unit) Trend (2013-2018)
Table Japan Drug-Eluting Stents Sales Volume (K Units) by Players (2013-2018)
Table Japan Drug-Eluting Stents Sales Volume Market Share by Players (2013-2018)
Figure Japan Drug-Eluting Stents Sales Volume Market Share by Players in 2017
Table Japan Drug-Eluting Stents Sales Volume (K Units) by Type (2013-2018)
Table Japan Drug-Eluting Stents Sales Volume Market Share by Type (2013-2018)
Figure Japan Drug-Eluting Stents Sales Volume Market Share by Type in 2017
Table Japan Drug-Eluting Stents Sales Volume (K Units) by Application (2013-2018)
Table Japan Drug-Eluting Stents Sales Volume Market Share by Application (2013-2018)
Figure Japan Drug-Eluting Stents Sales Volume Market Share by Application in 2017
Figure Southeast Asia Drug-Eluting Stents Sales (K Units) and Growth Rate (2013-2018)
Figure Southeast Asia Drug-Eluting Stents Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Drug-Eluting Stents Sales Price (USD/Unit) Trend (2013-2018)
Table Southeast Asia Drug-Eluting Stents Sales Volume (K Units) by Players (2013-2018)
Table Southeast Asia Drug-Eluting Stents Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Drug-Eluting Stents Sales Volume Market Share by Players in 2017
Table Southeast Asia Drug-Eluting Stents Sales Volume (K Units) by Type (2013-2018)
Table Southeast Asia Drug-Eluting Stents Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Drug-Eluting Stents Sales Volume Market Share by Type in 2017
Table Southeast Asia Drug-Eluting Stents Sales Volume (K Units) by Application (2013-2018)
Table Southeast Asia Drug-Eluting Stents Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Drug-Eluting Stents Sales Volume Market Share by Application in 2017
Figure India Drug-Eluting Stents Sales (K Units) and Growth Rate (2013-2018)
Figure India Drug-Eluting Stents Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Drug-Eluting Stents Sales Price (USD/Unit) Trend (2013-2018)
Table India Drug-Eluting Stents Sales Volume (K Units) by Players (2013-2018)
Table India Drug-Eluting Stents Sales Volume Market Share by Players (2013-2018)
Figure India Drug-Eluting Stents Sales Volume Market Share by Players in 2017
Table India Drug-Eluting Stents Sales Volume (K Units) by Type (2013-2018)
Table India Drug-Eluting Stents Sales Volume Market Share by Type (2013-2018)
Figure India Drug-Eluting Stents Sales Volume Market Share by Type in 2017
Table India Drug-Eluting Stents Sales Volume (K Units) by Application (2013-2018)
Table India Drug-Eluting Stents Sales Volume Market Share by Application (2013-2018)
Figure India Drug-Eluting Stents Sales Volume Market Share by Application in 2017
Table Abbott Vascular Basic Information List
Table Abbott Vascular Drug-Eluting Stents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Abbott Vascular Drug-Eluting Stents Sales Growth Rate (2013-2018)
Figure Abbott Vascular Drug-Eluting Stents Sales Global Market Share (2013-2018)
Figure Abbott Vascular Drug-Eluting Stents Revenue Global Market Share (2013-2018)
Table Advantec Vascular Basic Information List
Table Advantec Vascular Drug-Eluting Stents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Advantec Vascular Drug-Eluting Stents Sales Growth Rate (2013-2018)
Figure Advantec Vascular Drug-Eluting Stents Sales Global Market Share (2013-2018)
Figure Advantec Vascular Drug-Eluting Stents Revenue Global Market Share (2013-2018)
Table B.Braun Melsengen AG Basic Information List
Table B.Braun Melsengen AG Drug-Eluting Stents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure B.Braun Melsengen AG Drug-Eluting Stents Sales Growth Rate (2013-2018)
Figure B.Braun Melsengen AG Drug-Eluting Stents Sales Global Market Share (2013-2018
Figure B.Braun Melsengen AG Drug-Eluting Stents Revenue Global Market Share (2013-2018)
Table Biosensors Basic Information List
Table Biosensors Drug-Eluting Stents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Biosensors Drug-Eluting Stents Sales Growth Rate (2013-2018)
Figure Biosensors Drug-Eluting Stents Sales Global Market Share (2013-2018)
Figure Biosensors Drug-Eluting Stents Revenue Global Market Share (2013-2018)
Table Biotronik Basic Information List
Table Biotronik Drug-Eluting Stents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Biotronik Drug-Eluting Stents Sales Growth Rate (2013-2018)
Figure Biotronik Drug-Eluting Stents Sales Global Market Share (2013-2018)
Figure Biotronik Drug-Eluting Stents Revenue Global Market Share (2013-2018)
Table Blue Medical Basic Information List
Table Blue Medical Drug-Eluting Stents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Blue Medical Drug-Eluting Stents Sales Growth Rate (2013-2018)
Figure Blue Medical Drug-Eluting Stents Sales Global Market Share (2013-2018
Figure Blue Medical Drug-Eluting Stents Revenue Global Market Share (2013-2018)
Table Boston Scientific Basic Information List
Table Boston Scientific Drug-Eluting Stents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Boston Scientific Drug-Eluting Stents Sales Growth Rate (2013-2018)
Figure Boston Scientific Drug-Eluting Stents Sales Global Market Share (2013-2018)
Figure Boston Scientific Drug-Eluting Stents Revenue Global Market Share (2013-2018)
Table DISA Vascular Basic Information List
Table DISA Vascular Drug-Eluting Stents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure DISA Vascular Drug-Eluting Stents Sales Growth Rate (2013-2018)
Figure DISA Vascular Drug-Eluting Stents Sales Global Market Share (2013-2018
Figure DISA Vascular Drug-Eluting Stents Revenue Global Market Share (2013-2018)
Table Essen Basic Information List
Table Essen Drug-Eluting Stents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Essen Drug-Eluting Stents Sales Growth Rate (2013-2018)
Figure Essen Drug-Eluting Stents Sales Global Market Share (2013-2018)
Figure Essen Drug-Eluting Stents Revenue Global Market Share (2013-2018)
Table Medtronic Vascular Basic Information List
Table Medtronic Vascular Drug-Eluting Stents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Medtronic Vascular Drug-Eluting Stents Sales Growth Rate (2013-2018)
Figure Medtronic Vascular Drug-Eluting Stents Sales Global Market Share (2013-2018)
Figure Medtronic Vascular Drug-Eluting Stents Revenue Global Market Share (2013-2018)
Table MicroPort Medical Basic Information List
Table MIV Therapeutics Basic Information List
Table Orbusneich Basic Information List
Table Promed Medical Basic Information List
Table Relisys Medical Basic Information List
Table Reva Medical Basic Information List
Table Sahajanand Basic Information List
Table Sino Medical Basic Information List
Table Sorin Basic Information List
Table Terumo Medical Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drug-Eluting Stents
Figure Manufacturing Process Analysis of Drug-Eluting Stents
Figure Drug-Eluting Stents Industrial Chain Analysis
Table Raw Materials Sources of Drug-Eluting Stents Major Players in 2017
Table Major Buyers of Drug-Eluting Stents
Table Distributors/Traders List
Figure Global Drug-Eluting Stents Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Drug-Eluting Stents Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Drug-Eluting Stents Price (USD/Unit) and Trend Forecast (2018-2025)
Table Global Drug-Eluting Stents Sales Volume (K Units) Forecast by Regions (2018-2025)
Figure Global Drug-Eluting Stents Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Drug-Eluting Stents Sales Volume Market Share Forecast by Regions in 2025
Table Global Drug-Eluting Stents Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Drug-Eluting Stents Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Drug-Eluting Stents Revenue Market Share Forecast by Regions in 2025
Figure United States Drug-Eluting Stents Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Drug-Eluting Stents Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Drug-Eluting Stents Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Drug-Eluting Stents Revenue and Growth Rate Forecast (2018-2025)
Figure China Drug-Eluting Stents Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure China Drug-Eluting Stents Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Drug-Eluting Stents Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Drug-Eluting Stents Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Drug-Eluting Stents Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Drug-Eluting Stents Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Drug-Eluting Stents Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure India Drug-Eluting Stents Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Drug-Eluting Stents Sales (K Units) Forecast by Type (2018-2025)
Figure Global Drug-Eluting Stents Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Drug-Eluting Stents Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Drug-Eluting Stents Revenue Market Share Forecast by Type (2018-2025)
Table Global Drug-Eluting Stents Price (USD/Unit) Forecast by Type (2018-2025)
Table Global Drug-Eluting Stents Sales (K Units) Forecast by Application (2018-2025)
Figure Global Drug-Eluting Stents Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Pizotifen Market Research Report 2018
    Published: 18-Jul-2018        Price: US 2900 Onwards        Pages: 99
    This report studies the global Pizotifen market status and forecast, categorizes the global Pizotifen market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. The global Pizotifen market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025. The major manufacturer......
  • Urinary Incontinence - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 86
    Urinary Incontinence - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Urinary Incontinence - Pipeline Review, H2 2018, provides an overview of the Urinary Incontinence (Genito Urinary System And Sex Hormones) pipeline landscape. Urinary incontinence is a loss of control of the bladder. In some cases, it may result in a total loss of the bladder's contents or it may just cause minor leakag......
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 130
    Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2018, provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury) (Genito Urinary System And Sex Hormones) pipeline landscape. Acute kidney failure occurs when kidneys suddenly become unable to filter waste p......
  • Nocturia - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 33
    Nocturia - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nocturia - Pipeline Review, H2 2018, provides an overview of the Nocturia (Genito Urinary System And Sex Hormones) pipeline landscape. Nocturia is defined as need to urinate at least twice during the night. This condition becomes more common as people age and occurs in both men and women, sometimes for different reasons. Causes of ......
  • Secondary Hyperparathyroidism - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 38
    Secondary Hyperparathyroidism - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Secondary Hyperparathyroidism - Pipeline Review, H2 2018, provides an overview of the Secondary Hyperparathyroidism (Hormonal Disorders) pipeline landscape. Secondary hyperparathyroidism is occurs when the parathyroid glands in neck produce too much parathyroid hormone (PTH) because calcium levels are too low. ......
  • 72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC 3.4.24.24) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 32
    72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC 3.4.24.24) - Pipeline Review, H2 2018 Summary 72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC 3.4.24.24) pipeline Target constitutes close to 7 molecules. Out of which approximately 4 molecules are developed by companies and remaining by the ......
  • Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 48
    Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary According to the recently published report 'Ephrin Type B Receptor 4 - Pipeline Review, H2 2018'; Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) pipeline Target constitutes close to 6 molecules. Out of which approximately 3 molecules are developed by compa......
  • BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 129
    BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary According to the recently published report 'BDNF NT 3 Growth Factors Receptor - Pipeline Review, H2 2018'; BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK......
  • MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 41
    MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - Pipeline Review, H2 2018 Summary MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - MAP kinase-interacting serine/threonine-protein kinase 2 is an enzyme encoded by the MKNK2 gene. It phosphorylates SFPQ/PSF, HNRNPA1 and EIF4E. It plays a role in the response to environmental ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs